FDAnews Drug Daily Bulletin

Abbott Cholesterol Drug Subject of False-Marketing Suit

Aug. 23, 2012
A former Abbott Laboratories saleswoman has filed a federal lawsuit against the company, accusing it of illegally promoting its cholesterol drug TriCor for uses not approved by regulators, including the prevention of cardiac health risks in patients with diabetes.
Chicago Tribune